Bipolar Disorder

Neurobehavioral Disorders

Dexmedetomidine Oral Film Under Review for Agitation With Schizophrenia, Bipolar Disorder

By

Brian Park, PharmD

May 27, 2021

In both trials, BXCL501 demonstrated statistically significant, rapid and durable improvements vs placebo across multiple agitation scales.

Next post in Neurobehavioral Disorders

old man depression

Almost 1 in 4 Patients With Heart Failure Develop Depression